Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2 USD | +1.01% | +8.70% | +1.01% |
Financials (USD)
Sales 2024 * | 23.11M | Sales 2025 * | 18.17M | Capitalization | 162M |
---|---|---|---|---|---|
Net income 2024 * | -37M | Net income 2025 * | -33M | EV / Sales 2024 * | 7 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 8.9 x |
P/E ratio 2024 * |
-4.63
x | P/E ratio 2025 * |
-4.48
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 78.34% |
Latest transcript on ProQR Therapeutics N.V.
1 day | +1.01% | ||
1 week | +6.38% | ||
Current month | +2.56% | ||
1 month | -0.50% | ||
3 months | +1.01% | ||
6 months | +15.61% | ||
Current year | +1.01% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel de Boer
FOU | Founder | 41 | 12-02-20 |
Founder | 60 | 12-02-20 | |
Jurriaan Dekkers
DFI | Director of Finance/CFO | - | 22-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Domenico Valerio
FOU | Founder | 67 | 12-02-20 |
Founder | 60 | 12-02-20 | |
Alison Lawton
BRD | Director/Board Member | 62 | 14-09-16 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-04 | 2 | +1.01% | 128,642 |
24-06-03 | 1.98 | +1.54% | 68,397 |
24-05-31 | 1.95 | +6.56% | 64,672 |
24-05-30 | 1.83 | 0.00% | 162,934 |
24-05-29 | 1.83 | -0.54% | 90,679 |
Delayed Quote Nasdaq, June 04, 2024 at 03:59 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.01% | 162M | |
+16.73% | 121B | |
+13.04% | 107B | |
-5.80% | 24.82B | |
+1.69% | 22.48B | |
-10.09% | 18.32B | |
-40.52% | 16.33B | |
-14.00% | 15.31B | |
+1.18% | 14.08B | |
+24.18% | 11.74B |
- Stock Market
- Equities
- PRQR Stock